Group 1 - Blue Silicon Technology (300433.SZ) released its 2024 annual report on March 28, 2025, with 190 institutional investors holding a total of 3.804 billion shares, representing 76.34% of the total share capital [1] - The top ten institutional investors collectively hold 73.40% of the shares, with a slight decrease of 0.16 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two funds increased their holdings, accounting for a 0.26% increase, while six funds decreased their holdings, representing a 0.10% decrease [2] - A total of 14 new public funds were disclosed this period, while 123 funds were not disclosed compared to the previous quarter [2] - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 0.19% [2]

Group 1 - The core viewpoint of the news is that as of March 27, 2025, institutional investors hold a significant portion of Tiger Medical's A-shares, totaling 1.76 billion shares, which accounts for 20.31% of the company's total equity [1] - The top ten institutional investors collectively hold 14.86% of Tiger Medical's shares, with a decrease of 1.43 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two funds increased their holdings, while five funds decreased their holdings, with a total reduction rate of 0.19% [2] - A total of 16 new public funds were disclosed this period, including notable funds such as E Fund CSI 300 Medical ETF and others [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.30% compared to the previous quarter [2]